Objective:

To explore the expression and functional role of FOXI3 in prostate cancer progression, particularly in relation to bone metastases and its interaction with FGF8.

Approach:

Key Findings:

• FOXI3 expression is associated with tumor pathology and increasing tumor grade in prostate cancer.
• FOXI3 is elevated in bone metastases and correlates with FGF8 expression.
• FGF8 treatment increases FOXI3 RNA expression in bone-derived prostate cancer cells.
• The FGF8–FOXI3 axis regulates migration and proliferation of bone-derived prostate cancer cells.

Interpretation:

The findings indicate a role for FOXI3 in prostate cancer progression, particularly in bone metastasis, influenced by FGF8.

Limitations:

• The study primarily focuses on in vitro analyses, which may not fully replicate in vivo conditions.
• Further investigation is needed to clarify the specific mechanisms of FOXI3's role in tumor progression.

Conclusion:

This study highlights the importance of FOXI3 in prostate cancer metastasis to bone and its regulatory relationship with FGF8.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.